Cytokinetics | CYTK - Interest Expense On Debt


Cytokinetics reported $33.34M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Acadia Pharmaceuticals USD 0 4.12M Sep/2024
Amgen USD 657M 4M Mar/2026
Arca Biopharma USD 504K 246K Sep/2024
Bayer EUR 675M 87M Dec/2025
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 411M 21M Mar/2026
Capricor Therapeutics 3.05M 2.46M Dec/2025
Cytokinetics USD 33.34M 3M Mar/2026
Eisai JPY 1.55B 117M Mar/2026
Eli Lilly USD 114.7M 134.3M Sep/2025
Exelixis USD 23.4M 3.9M Sep/2023
Geron USD 7.15M 150K Mar/2026
Halozyme Therapeutics USD 5.51M 597K Mar/2026
Ionis Pharmaceuticals USD 17M 1000K Mar/2026
Ligand Pharmaceuticals USD 1.78M 875K Dec/2025
Merck USD 479M 67M Mar/2026
Novartis USD 343M 39M Mar/2026
Pfizer USD 671M 40M Mar/2026
Regeneron Pharmaceuticals USD 12.9M 700K Mar/2026
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR 178M 203M Mar/2026